CNO Financial Group CNO Supplemental health — Deferred Policy Acquisition Costs, Amortization Expense
Other product segments
Other financials
Where this comes from
Reported directly by CNO Financial Group in its filing.
Tagged under the XBRL concept us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense.
The official record: CNO Financial Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CNO Financial Group's supplemental health — deferred policy acquisition costs, amortization expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CNO Financial Group's supplemental health — deferred policy acquisition costs, amortization expense?
- CNO Financial Group (CNO) reported supplemental health — deferred policy acquisition costs, amortization expense of $10M in Q1 2026.
- How has CNO Financial Group's supplemental health — deferred policy acquisition costs, amortization expense changed year-over-year?
- CNO Financial Group's supplemental health — deferred policy acquisition costs, amortization expense increased by 8.7% year-over-year, from $9.2M to $10M.
- What is the long-term trend for CNO Financial Group's supplemental health — deferred policy acquisition costs, amortization expense?
- Over 4 years (2021 to 2025), CNO Financial Group's supplemental health — deferred policy acquisition costs, amortization expense has grown at a 8.0% compound annual growth rate (CAGR), from $27.7M to $37.7M.
- What does supplemental health — deferred policy acquisition costs, amortization expense mean?
- This metric represents the periodic expense recognized from the systematic amortization of costs directly associated with acquiring new insurance policies. It reflects the allocation of upfront marketing, underwriting, and commission expenses over the expected life of the supplemental health insurance contracts. Monitoring this expense provides insight into the efficiency of customer acquisition strategies and the long-term profitability of the supplemental health product portfolio.